AG2R La Mondiale Gestion d'Actifs’s Edwards Lifesciences EW Stock Holding History

AG2R La Mondiale Gestion d'Actifs’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.45M	Buy	27,136 +679	+3%	+$56.9K	0.09%	208
2026 Q1	$2.12M	Buy	26,457 +350	+1%	+$28.9K	0.1%	202
2025 Q4	$2.23M	Buy	26,107 +949	+4%	+$77.9K	0.1%	183
2025 Q3	$1.97M	Hold	25,158	–	–	0.1%	191
2025 Q2	$1.97M	Buy	25,158 +721	+3%	+$53.8K	0.1%	191
2025 Q1	$1.91M	Buy	+24,437	New	+$1.75M	0.1%	185

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

AG2R La Mondiale Gestion d'Actifs's EW Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its Edwards Lifesciences (EW) stake by 2.6% in Q2 2026, buying an estimated $56.9K and bringing the position to 27,136 shares worth $2.45M. The position accounts for 0.09% of the portfolio, ranked #208.

AG2R La Mondiale Gestion d'Actifs first reported a position in EW in Q1 2025 and has held it in 6 quarters since. 327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

AG2R La Mondiale Gestion d'Actifs held 27,136 shares of Edwards Lifesciences worth $2.45M as of Q2 2026.
AG2R La Mondiale Gestion d'Actifs bought 679 Edwards Lifesciences shares in Q2 2026, an estimated $56.9K.
Edwards Lifesciences made up 0.09% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #208 holding.
AG2R La Mondiale Gestion d'Actifs first reported a position in Edwards Lifesciences in Q1 2025 and has held it in 6 quarters since.
327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.